Top 7 large- and mid-cap healthcare stocks that have given at least 88% return in 1 year
Healthcare stocks have been one of the stock gainers in the last one years. Their rise quickened specially after the coronavirus pandemic when the demand for medicines and healthcare facilities increased many folds. One of its main indices, S&P BSE Healthcare Index, has risen by over 50 per cent in the last 1 year. Many of the large- and mid-cap health stocks in S&P BSE Healthcare Index. Here is the list of them.
Photos: Pixabay/Unsplash
Wockhardt Ltd
The mid-cap stock has risen by 205.36% in the 1-year period. The market value of the company is Rs 8,298.63 crore, while its stock closed trading on Monday at Rs 541.
Strides Pharma Science
The mid-cap stock has soared by 131.55% in the 1 year. Its market value is Rs 7,811.41 crore while its share closed trading at Rs 849.90.
Lupin
Lupin has also been a multibagger with 117.67% return in the 1-year period. The market value for the large-cap pharma firm is Rs 76,748.32 crore while the stock closed trading at Rs 1,684.00.
Piramal Pharma
Another large-cap stock in the list has skyrocketed by 105.66%. The company's market value is Rs 20,419.70 crore, while its stock price at market close on Monday is Rs 154.35.
Zydus Lifesciences
The stock of this large-cap pharma company has soared by 93.49% in the 1 year. The market value of the company is Rs 99,959.28 crore, while its stock closed trading on Monday at Rs 993.40.
Aurobindo Pharma
The large-cap stock has given 93.06% return in the 1-year period. It carries a market value of Rs 69,014.78 crore, while the stock's price at the close of market on Monday was Rs 1,181.00.
Ajanta Pharma
Another large-cap stock has risen by 88.80%. The market value of the firm is Rs 29,903.71 crore, while the stock closed trading at Rs 2,374.90 on Monday.